Low-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer Survivors
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Tamoxifen Citrate|DRUG: Placebo|PROCEDURE: Digital mammography|OTHER: immunohistochemistry staining method|OTHER: pharmacological study|OTHER: laboratory biomarker analysis|GENETIC: protein expression analysis|OTHER: pharmacogenomic studies|OTHER: questionnaire administration|PROCEDURE: Fine needle aspiration|OTHER: Quality of Life Assessment
Sponsor: University of Alabama at Birmingham
Collaborators: National Cancer Institute (NCI)|St. Jude Children's Research Hospital|University Health Network, Toronto|University of Michigan|Dana-Farber Cancer Institute|Mayo Clinic|University of Washington|City of Hope National Medical Center|M.D. Anderson Cancer Center|University of Chicago|University of Minnesota|University of Colorado, Denver|Wake Forest University